Key result
Long-term in vivo administration of nitroglycerine significantly reduced ACh-induced endothelium-dependent relaxation in rabbit intrapulmonary veins, which was normalized by valsartan.
Why the study?
Does valsartan normalize the attenuated endothelium-dependent relaxation caused by long-term nitroglycerine administration in rabbit intrapulmonary veins?
Does valsartan normalize the attenuated endothelium-dependent relaxation caused by long-term nitroglycerine administration in rabbit intrapulmonary veins?
Long-term nitroglycerine administration downregulates endothelium-dependent relaxation in rabbit intrapulmonary veins via AT1 receptor-mediated mechanisms, which can be normalized by valsartan.
Answers are grounded in this paper and cite their sources.
Valsartan may counteract chronic nitroglycerin effects on pulmonary vein relaxation; hypothesis-generating from rabbit data only.
1 This study was undertaken to determine whether long-term in vivo administration of nitroglycerine (NTG) downregulates the endothelium-dependent relaxation induced by acetylcholine (ACh) in the rabbit intrapulmonary vein and, if so, whether the type 1 angiotensin II receptor (AT(1)R) blocker valsartan normalizes this downregulated relaxation. 2 In strips treated with the cyclooxygenase inhibitor diclofenac, ACh induced a relaxation only when the endothelium was intact. A small part of this ACh-induced relaxation was inhibited by coapplication of two Ca(2+)-activated K(+)-channel blockers (charybdotoxin (CTX)+apamin) and the greater part of the response was inhibited by the nitric-oxide-synthase inhibitor N(omega)-nitro-L-arginine (L-NNA). 3 The endothelium-dependent relaxation induced by ACh, but not the endothelium-independent relaxation induced by the nitric oxide donor NOC-7, was significantly reduced in NTG-treated rabbits (versus those in NTG-nontreated control rabbits). The attenuated relaxation was normalized by coapplication of valsartan with the NTG. 4 In the vascular wall, both the amount of localized angiotensin II and the production of superoxide anion were increased by in vivo NTG treatment. These variables were normalized by coapplication of valsartan with the NTG. 5 It is suggested that long-term in vivo administration of NTG downregulates the ACh-induced endothelium-dependent relaxation, mainly through an inhibition of endothelial nitric oxide production in the rabbit intrapulmonary vein. A possible role for AT(1)R is proposed in the mechanism underlying this effect.
No takes yet. Share an insight, caveat, or question.
Kusama et al. (2005) studied this question. Nitroglycerine (NTG) with or without valsartan vs. NTG-nontreated control was evaluated on Endothelium-dependent relaxation induced by acetylcholine (ACh). Long-term in vivo administration of nitroglycerine significantly reduced ACh-induced endothelium-dependent relaxation in rabbit intrapulmonary veins, which was normalized by valsartan.
Synapse has enriched 10 related papers. Consider them for comparative context: